Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-27 |
Sentence |
denotes |
Paraneoplastic Scleroderma: |
T1 |
0-27 |
Sentence |
denotes |
Paraneoplastic Scleroderma: |
T2 |
28-48 |
Sentence |
denotes |
Are There Any Clues? |
T2 |
28-48 |
Sentence |
denotes |
Are There Any Clues? |
T3 |
49-152 |
Sentence |
denotes |
Dear Editor, Scleroderma associated with neoplasia is rare, with only a small number of cases reported. |
T3 |
49-152 |
Sentence |
denotes |
Dear Editor, Scleroderma associated with neoplasia is rare, with only a small number of cases reported. |
T4 |
153-234 |
Sentence |
denotes |
We describe 4 patients with paraneoplastic scleroderma who were treated at the I. |
T4 |
153-234 |
Sentence |
denotes |
We describe 4 patients with paraneoplastic scleroderma who were treated at the I. |
T5 |
235-328 |
Sentence |
denotes |
Department of Dermatovenereology, St. Anna Hospital, during the period between 2004 and 2014. |
T5 |
235-328 |
Sentence |
denotes |
Department of Dermatovenereology, St. Anna Hospital, during the period between 2004 and 2014. |
T6 |
329-473 |
Sentence |
denotes |
The patients were diagnosed with cholangiogenic carcinoma, endometrial carcinoma, prostatic adenocarcinoma, and adenoma of the suprarenal gland. |
T6 |
329-473 |
Sentence |
denotes |
The patients were diagnosed with cholangiogenic carcinoma, endometrial carcinoma, prostatic adenocarcinoma, and adenoma of the suprarenal gland. |
T7 |
474-736 |
Sentence |
denotes |
In the case of concurrent scleroderma and tumor, four situations may occur: they can develop independently of each other; scleroderma may be induced by the tumor; the tumor can develop in the scleroderma; or the tumor can be induced by immunosuppressive therapy. |
T7 |
474-736 |
Sentence |
denotes |
In the case of concurrent scleroderma and tumor, four situations may occur: they can develop independently of each other; scleroderma may be induced by the tumor; the tumor can develop in the scleroderma; or the tumor can be induced by immunosuppressive therapy. |
T8 |
737-950 |
Sentence |
denotes |
Sclerotization of the skin was described in association with lung cancer, carcinoid, plasma cell dyscrasia, cancer of the ovary, cervix, breast, esophagus, stomach, nasopharynx, melanoma, and sarcoma (1,2,5,7,10). |
T8 |
737-950 |
Sentence |
denotes |
Sclerotization of the skin was described in association with lung cancer, carcinoid, plasma cell dyscrasia, cancer of the ovary, cervix, breast, esophagus, stomach, nasopharynx, melanoma, and sarcoma (1,2,5,7,10). |
T9 |
951-1043 |
Sentence |
denotes |
Symptoms may be induced by substances secreted by the tumor (hormones, cytokines, etc.) (9). |
T9 |
951-1043 |
Sentence |
denotes |
Symptoms may be induced by substances secreted by the tumor (hormones, cytokines, etc.) (9). |
T10 |
1044-1110 |
Sentence |
denotes |
Tumorous cells further induce cytotoxic and autoantibody response. |
T10 |
1044-1110 |
Sentence |
denotes |
Tumorous cells further induce cytotoxic and autoantibody response. |
T11 |
1111-1259 |
Sentence |
denotes |
Scleroderma is characterized by immunological dysregulation, vasculopathy, and hyperproduction of the extracellular matrix by activated fibroblasts. |
T11 |
1111-1259 |
Sentence |
denotes |
Scleroderma is characterized by immunological dysregulation, vasculopathy, and hyperproduction of the extracellular matrix by activated fibroblasts. |
T12 |
1260-1547 |
Sentence |
denotes |
Endothelial, inflammatory, and mesenchymal cells produce cytokines, chemokines, and growth factors e.g. Interleukin-1 (IL1), Interleukin-6 (IL6), tumor necrosis factor alpha (TNF α), collagen alpha 1, connective tissue growth factor (CTGF) (3), and basic fibroblast growth factor (bFGF). |
T12 |
1260-1547 |
Sentence |
denotes |
Endothelial, inflammatory, and mesenchymal cells produce cytokines, chemokines, and growth factors e.g. Interleukin-1 (IL1), Interleukin-6 (IL6), tumor necrosis factor alpha (TNF α), collagen alpha 1, connective tissue growth factor (CTGF) (3), and basic fibroblast growth factor (bFGF). |
T13 |
1548-1602 |
Sentence |
denotes |
This factor is also produced by lung cancer cells (4). |
T13 |
1548-1602 |
Sentence |
denotes |
This factor is also produced by lung cancer cells (4). |
T14 |
1603-1681 |
Sentence |
denotes |
The clinical picture of scleroderma and paraneoplastic scleroderma is similar. |
T14 |
1603-1681 |
Sentence |
denotes |
The clinical picture of scleroderma and paraneoplastic scleroderma is similar. |
T15 |
1682-1756 |
Sentence |
denotes |
Diffuse thickening of the skin and/or sclerodermatous plaques can be seen. |
T15 |
1682-1756 |
Sentence |
denotes |
Diffuse thickening of the skin and/or sclerodermatous plaques can be seen. |
T16 |
1757-1813 |
Sentence |
denotes |
The histological picture is consistent with scleroderma. |
T16 |
1757-1813 |
Sentence |
denotes |
The histological picture is consistent with scleroderma. |
T17 |
1814-1961 |
Sentence |
denotes |
Capillaroscopy changes, antinuclear antibodies (ANA), sclerodactyly, and Raynaud phenomenon suggest the diagnosis of systemic scleroderma (SS) (4). |
T17 |
1814-1961 |
Sentence |
denotes |
Capillaroscopy changes, antinuclear antibodies (ANA), sclerodactyly, and Raynaud phenomenon suggest the diagnosis of systemic scleroderma (SS) (4). |
T18 |
1962-2021 |
Sentence |
denotes |
Our patients did not fulfill enough of the criteria for SS. |
T18 |
1962-2021 |
Sentence |
denotes |
Our patients did not fulfill enough of the criteria for SS. |
T19 |
2022-2134 |
Sentence |
denotes |
Both diffuse and localized scleroderma was seen in 3 patients and generalized localized scleroderma in one case. |
T19 |
2022-2134 |
Sentence |
denotes |
Both diffuse and localized scleroderma was seen in 3 patients and generalized localized scleroderma in one case. |
T20 |
2135-2256 |
Sentence |
denotes |
All patients had a histological picture consistent with scleroderma, negative ANA and ENA antibodies (Table 1, Figure 1). |
T20 |
2135-2256 |
Sentence |
denotes |
All patients had a histological picture consistent with scleroderma, negative ANA and ENA antibodies (Table 1, Figure 1). |
T21 |
2257-2391 |
Sentence |
denotes |
A 66-year-old woman presented with a 10 months history of sclerodermatous plaques on her neck, trunk, and upper and lower extremities. |
T21 |
2257-2391 |
Sentence |
denotes |
A 66-year-old woman presented with a 10 months history of sclerodermatous plaques on her neck, trunk, and upper and lower extremities. |
T22 |
2392-2451 |
Sentence |
denotes |
The skin on her breasts and cheeks was diffusely indurated. |
T22 |
2392-2451 |
Sentence |
denotes |
The skin on her breasts and cheeks was diffusely indurated. |
T23 |
2452-2731 |
Sentence |
denotes |
Examination showed thrombocytopenia, elevated transaminases, Cancer antigen 19-9 (Ca 19-9), thyroid stimulating hormone (TSH), and anti-thyroid peroxidase antibodies, dysmotility of the lower part of esophagus, hepatosplenomegaly, cholecystolithiasis, and benign polyps of colon. |
T23 |
2452-2731 |
Sentence |
denotes |
Examination showed thrombocytopenia, elevated transaminases, Cancer antigen 19-9 (Ca 19-9), thyroid stimulating hormone (TSH), and anti-thyroid peroxidase antibodies, dysmotility of the lower part of esophagus, hepatosplenomegaly, cholecystolithiasis, and benign polyps of colon. |
T24 |
2732-2800 |
Sentence |
denotes |
She was given prednisone 40 mg/day but did not return for follow up. |
T24 |
2732-2800 |
Sentence |
denotes |
She was given prednisone 40 mg/day but did not return for follow up. |
T25 |
2801-2916 |
Sentence |
denotes |
After 6 months she was diagnosed with cholangiogenic carcinoma with metastatic disease and died shortly afterwards. |
T25 |
2801-2916 |
Sentence |
denotes |
After 6 months she was diagnosed with cholangiogenic carcinoma with metastatic disease and died shortly afterwards. |
T26 |
2917-2992 |
Sentence |
denotes |
A 74-year-old woman had localized scleroderma on the trunk for three years. |
T26 |
2917-2992 |
Sentence |
denotes |
A 74-year-old woman had localized scleroderma on the trunk for three years. |
T27 |
2993-3090 |
Sentence |
denotes |
She was treated with procaine penicillin for positive borrelia Immunoglobulin M (IgM) antibodies. |
T27 |
2993-3090 |
Sentence |
denotes |
She was treated with procaine penicillin for positive borrelia Immunoglobulin M (IgM) antibodies. |
T28 |
3091-3288 |
Sentence |
denotes |
Her condition worsened suddenly with confluent scleroderma plaques on her trunk, extremities, and genital region, and vasoneurosis on her lower extremities; she was started on prednisone 35 mg/day. |
T28 |
3091-3288 |
Sentence |
denotes |
Her condition worsened suddenly with confluent scleroderma plaques on her trunk, extremities, and genital region, and vasoneurosis on her lower extremities; she was started on prednisone 35 mg/day. |
T29 |
3289-3329 |
Sentence |
denotes |
Examination revealed endometrial cancer. |
T29 |
3289-3329 |
Sentence |
denotes |
Examination revealed endometrial cancer. |
T30 |
3330-3419 |
Sentence |
denotes |
The patient underwent a hysterectomy, adnexectomy, and radiotherapy with curative effect. |
T30 |
3330-3419 |
Sentence |
denotes |
The patient underwent a hysterectomy, adnexectomy, and radiotherapy with curative effect. |
T31 |
3420-3525 |
Sentence |
denotes |
Scleroderma patches softened with residual hyperpigmentation, and prednisone was stopped two years later. |
T31 |
3420-3525 |
Sentence |
denotes |
Scleroderma patches softened with residual hyperpigmentation, and prednisone was stopped two years later. |
T32 |
3526-3697 |
Sentence |
denotes |
A 80-year-old man had a month-long history of diffuse thickening and toughening of the skin on the forearms and lower legs and scleroderma patches on the thighs and shins. |
T32 |
3526-3697 |
Sentence |
denotes |
A 80-year-old man had a month-long history of diffuse thickening and toughening of the skin on the forearms and lower legs and scleroderma patches on the thighs and shins. |
T33 |
3698-3824 |
Sentence |
denotes |
Examination revealed prostate adenocarcinoma, and therapy with antiandrogen bicalutamide and prednisone 15 mg/day was started. |
T33 |
3698-3824 |
Sentence |
denotes |
Examination revealed prostate adenocarcinoma, and therapy with antiandrogen bicalutamide and prednisone 15 mg/day was started. |
T34 |
3825-3978 |
Sentence |
denotes |
Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs. |
T34 |
3825-3978 |
Sentence |
denotes |
Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs. |
T35 |
3979-4125 |
Sentence |
denotes |
A 62-year-old woman with seronegative rheumatoid arthritis presented with diffusely tough skin on her extremities and trunk, present for 2 months. |
T35 |
3979-4125 |
Sentence |
denotes |
A 62-year-old woman with seronegative rheumatoid arthritis presented with diffusely tough skin on her extremities and trunk, present for 2 months. |
T36 |
4126-4291 |
Sentence |
denotes |
Examination revealed cervicitis with a benign endometric polyp, cholecystolithiasis, borderline pulmonary hypertension, and a hormonally inactive suprarenal adenoma. |
T36 |
4126-4291 |
Sentence |
denotes |
Examination revealed cervicitis with a benign endometric polyp, cholecystolithiasis, borderline pulmonary hypertension, and a hormonally inactive suprarenal adenoma. |
T37 |
4292-4357 |
Sentence |
denotes |
She was given prednisone 40 mg/day and penicillamine with effect. |
T37 |
4292-4357 |
Sentence |
denotes |
She was given prednisone 40 mg/day and penicillamine with effect. |
T38 |
4358-4477 |
Sentence |
denotes |
In the 3rd year of therapy she has residual induration of her lower legs and a scleroderma plaque in the lumbar region. |
T38 |
4358-4477 |
Sentence |
denotes |
In the 3rd year of therapy she has residual induration of her lower legs and a scleroderma plaque in the lumbar region. |
T39 |
4478-4522 |
Sentence |
denotes |
She is monitored for her suprarenal adenoma. |
T39 |
4478-4522 |
Sentence |
denotes |
She is monitored for her suprarenal adenoma. |
T40 |
4523-4742 |
Sentence |
denotes |
Two patients had scleroderma at the same time as a malignant tumor; in one patient the localized scleroderma worsened rapidly at the time of the tumor diagnosis, and in one patient a clinically silent adenoma was found. |
T40 |
4523-4742 |
Sentence |
denotes |
Two patients had scleroderma at the same time as a malignant tumor; in one patient the localized scleroderma worsened rapidly at the time of the tumor diagnosis, and in one patient a clinically silent adenoma was found. |
T41 |
4743-4837 |
Sentence |
denotes |
Adrenal tissue can secrete molecules such as serotonine or bFGF involved in fibroplasia (3,6). |
T41 |
4743-4837 |
Sentence |
denotes |
Adrenal tissue can secrete molecules such as serotonine or bFGF involved in fibroplasia (3,6). |
T42 |
4838-5042 |
Sentence |
denotes |
One patient died of a metastatic disease, two patients after the successful treatment of the tumor, and the patient with suprarenal adenoma experienced softening of the skin and regression of scleroderma. |
T42 |
4838-5042 |
Sentence |
denotes |
One patient died of a metastatic disease, two patients after the successful treatment of the tumor, and the patient with suprarenal adenoma experienced softening of the skin and regression of scleroderma. |
T43 |
5043-5192 |
Sentence |
denotes |
Although paraneoplastic scleroderma is often classified as a pseudoscleroderma, we regard neoplasia as a distinct triggering impulse for scleroderma. |
T43 |
5043-5192 |
Sentence |
denotes |
Although paraneoplastic scleroderma is often classified as a pseudoscleroderma, we regard neoplasia as a distinct triggering impulse for scleroderma. |
T44 |
5193-5311 |
Sentence |
denotes |
Recently, an association between RNA polymerase I/III antibodies in systemic scleroderma and cancer was suggested (8). |
T44 |
5193-5311 |
Sentence |
denotes |
Recently, an association between RNA polymerase I/III antibodies in systemic scleroderma and cancer was suggested (8). |
T45 |
5312-5386 |
Sentence |
denotes |
Such studies may confirm the true link between scleroderma and malignancy. |
T45 |
5312-5386 |
Sentence |
denotes |
Such studies may confirm the true link between scleroderma and malignancy. |
T46 |
5387-5544 |
Sentence |
denotes |
These patients are characterized by older age, sudden onset, diffuse thickening of the skin, and/or generalized morphea with a concurrent neoplastic process. |
T46 |
5387-5544 |
Sentence |
denotes |
These patients are characterized by older age, sudden onset, diffuse thickening of the skin, and/or generalized morphea with a concurrent neoplastic process. |
T47 |
5545-5611 |
Sentence |
denotes |
In the case of a successful tumor treatment, skin changes regress. |
T47 |
5545-5611 |
Sentence |
denotes |
In the case of a successful tumor treatment, skin changes regress. |